4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001193125-26-265965
Options or other derivatives
- Director acquired 76,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2026-06-09 | Grant or award · Non-Qualified Stock Option (right to buy) | +38,000 | 38,000 | I | ||
| BAKER BROS. ADVISORS LP Director | 2026-06-09 | Grant or award · Non-Qualified Stock Option (right to buy) | +38,000 | 38,000 | I | ||
Loading xslF345X06/ownership.xml…